CH14.18 1021 Antibody and IL2 After Haplo SCT in Children With Relapsed Neuroblastoma
Clinical trial NCT02258815 · COMPLETED
Trial details
- NCT number
- NCT02258815
- Sponsor
- University Children's Hospital Tuebingen
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-01
- Primary completion
- 2018-11-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.